Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 409
Selected: 0
NCT IDTitle
NCT00910676Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors
NCT00144976Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma
NCT00938444Evaluation of the BRADA and ABILHAND Questionnaires
NCT00438152Lopinavir Capsules to Kaletra or Invirase Tablets
NCT03802604Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer
NCT01524679Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen
NCT00774462Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
NCT00673920A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy
NCT01426880Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer
NCT04363853Tocilizumab Treatment in Patients With COVID-19
NCT00275665The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.
NCT00483405Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
NCT04808245A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
NCT07542678Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept
NCT05525858KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
NCT01713218Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer
NCT03679455A Study of Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobulinemia, OBI-1
NCT01196455Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer
NCT05919342Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
NCT00509184Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma
NCT01674738TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
NCT05057234PRecision Oncology Evidence Development in Cancer Treatment - Liquid
NCT00944684High Dose Ribavirin in the Treatment of Chronic Hepatitis C
NCT01208896Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma
NCT00112931Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
NCT05825261Exploring Novel Biomarkers for Emphysema Detection
NCT02671071Prospective Evaluation of Patients With Uterine Cervical Cancer in Brazilian Health Institutions - The EVITA I Study
NCT00963534Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
NCT02012634Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
NCT03526601Screening Of Adult urBan pOpulation To diAgnose Heart Failure
NCT01640444Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)
NCT01059630A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
NCT00815867Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant
NCT00333736Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration
NCT00193609Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
NCT02308527Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
NCT05300282Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
NCT03449914The GOLD Study: G8 in OLDer Patients
NCT00363116A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
NCT00842114Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)
NCT03831490Study for Improving Maternal, Pregnancy and Child Outcomes
NCT00201825A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients
NCT035905355th Generation cTnT in ED ACS
NCT01790633Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests
NCT01832415First Line Ovarian Cancer Treatment - Cohort Study
NCT00396435Correction of Anaemia and Progression of Renal Failure on Transplanted Patients
NCT00264290Valganciclovir to Reduce T Cell Activation in HIV Infection
NCT00316420Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer
NCT00095901Capecitabine For Nasopharyngeal Cancer
NCT00539838A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)